128
J. Cosmet. Sci., 75.2, 128–145 (March/April 2024)
*Address all correspondence to Danielle Guimarães Almeida Diniz, danielle_diniz@ufg.br
Improved Photostability and Skin Retention of Avobenzone
Encapsulated in Compatible Nanostructured Lipid Carriers
ISABELLY PAULA SOUSA, AMANDA CECÍLIA TEODORO LANDIM, BÁRBARA
CRISTINA CAMPOS RIBEIRO, EMILIO RAMOS CINTRA, LORENA MAIONE SILVA,
THAIS LEITE NASCIMENTO, ELIANA MARTINS LIMA, LUÍS ANTÔNIO DANTAS
SILVA AND DANIELLE GUIMARÃES ALMEIDA DINIZ
Laboratory of Pharmaceutical Technology and Drug Delivery Systems, Federal University of Goias, Brazil
(I.P.S., A.C.T.L., B.C.C.R., E.R.C., L.M.S., T.L.N., E.M.L., L.A.D.S., D.G.A.D.)
State University of Goias, Brazil (L.M.S.)
Accepted for publication February 28, 2024.
Synopsis
Avobenzone (AVB) is an organic filter acting in the UVA spectrum. To exert its photoprotective effect, AVB
must be protected from UV radiation since it can suffer photoisomerization and incur adverse effects, such
as endocrine and metabolic disruption. Nanostructured carriers are an interesting strategy for protecting
the molecule and reducing skin permeation. This study aimed to improve AVB photostability and skin
retention through encapsulation in nanostructured lipid carriers. Our results showed that nanoencapsulation
in carnauba wax-nanostructured lipid carriers prepared with compatible lipid excipients proved to be an
efficient strategy in preventing AVB photo-instability. The formulation showed improved skin retention,
could be further investigated as a carrier to overcome AVB limitations as a long-wave UVA filter, and may
contribute to improving the efficiency and safety of this active cosmetic ingredient.
INTRODUCTION
Nonmelanoma skin cancer is the most common human malignancy worldwide, with
increasing yearly incidence rates.1 Even with this high incidence, the disease has low
mortality and a high probability of remission. Some important risk factors are related
to the disease, such as genetic predisposition, skin phenotypes, and prolonged exposure
to UV radiation without proper use of UV protection.2,3 There is a growing need for
more effective topical sunscreens to prevent the harmful effects of UV radiation on
human skin.4 While most sunscreens provide excellent protection against UVB radiation,
adequate protection against UVA radiation is becoming increasingly necessary.5 Studies
highlight the significant role played by UVA radiation in sunlight-induced skin damage
and changes, such as immunosuppression, DNA mutations, lipid and protein oxidative
damage, increased epidermal ferritin expression, skin photoaging, and decreased skin
J. Cosmet. Sci., 75.2, 128–145 (March/April 2024)
*Address all correspondence to Danielle Guimarães Almeida Diniz, danielle_diniz@ufg.br
Improved Photostability and Skin Retention of Avobenzone
Encapsulated in Compatible Nanostructured Lipid Carriers
ISABELLY PAULA SOUSA, AMANDA CECÍLIA TEODORO LANDIM, BÁRBARA
CRISTINA CAMPOS RIBEIRO, EMILIO RAMOS CINTRA, LORENA MAIONE SILVA,
THAIS LEITE NASCIMENTO, ELIANA MARTINS LIMA, LUÍS ANTÔNIO DANTAS
SILVA AND DANIELLE GUIMARÃES ALMEIDA DINIZ
Laboratory of Pharmaceutical Technology and Drug Delivery Systems, Federal University of Goias, Brazil
(I.P.S., A.C.T.L., B.C.C.R., E.R.C., L.M.S., T.L.N., E.M.L., L.A.D.S., D.G.A.D.)
State University of Goias, Brazil (L.M.S.)
Accepted for publication February 28, 2024.
Synopsis
Avobenzone (AVB) is an organic filter acting in the UVA spectrum. To exert its photoprotective effect, AVB
must be protected from UV radiation since it can suffer photoisomerization and incur adverse effects, such
as endocrine and metabolic disruption. Nanostructured carriers are an interesting strategy for protecting
the molecule and reducing skin permeation. This study aimed to improve AVB photostability and skin
retention through encapsulation in nanostructured lipid carriers. Our results showed that nanoencapsulation
in carnauba wax-nanostructured lipid carriers prepared with compatible lipid excipients proved to be an
efficient strategy in preventing AVB photo-instability. The formulation showed improved skin retention,
could be further investigated as a carrier to overcome AVB limitations as a long-wave UVA filter, and may
contribute to improving the efficiency and safety of this active cosmetic ingredient.
INTRODUCTION
Nonmelanoma skin cancer is the most common human malignancy worldwide, with
increasing yearly incidence rates.1 Even with this high incidence, the disease has low
mortality and a high probability of remission. Some important risk factors are related
to the disease, such as genetic predisposition, skin phenotypes, and prolonged exposure
to UV radiation without proper use of UV protection.2,3 There is a growing need for
more effective topical sunscreens to prevent the harmful effects of UV radiation on
human skin.4 While most sunscreens provide excellent protection against UVB radiation,
adequate protection against UVA radiation is becoming increasingly necessary.5 Studies
highlight the significant role played by UVA radiation in sunlight-induced skin damage
and changes, such as immunosuppression, DNA mutations, lipid and protein oxidative
damage, increased epidermal ferritin expression, skin photoaging, and decreased skin